Next-gen Berberine bioavailability breakthrough

Explore the clinical validation of BioBerb®, a next-generation berberine formulation. Using LipiSperse®, an advanced delivery system technology, to overcome poor natural absorption. In a randomized, double-blind study, BioBerb® demonstrated significantly higher plasma levels, with 70% higher total berberine absorption and 80% higher peak concentration compared to standard berberine. This session highlights the implications of enhanced bioavailability for therapeutic efficacy and sets a new benchmark for berberine supplementation in health span and wellness applications.

Speaker:

• Dr. Amanda Rao, RDC Global